Dr Reddy's Laboratories (DRREDDY) News Today Add Share Share Headlines Stock AnalysisBuy This Stock DRREDDY Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent September 2025 August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 Time Period RailTel, Dr Reddy's, Adani Power among stocks in focus next week; here's whySeptember 13 at 11:18 PM | msn.comDr Reddy's Labs gets five USFDA observations for Bachupally unitSeptember 13 at 8:14 AM | msn.comDr Reddy’s Expands Portfolio With Stugeron Buy – SEBI Analysts Flag Cost Risks But See Medium-Term GainsSeptember 11, 2025 | msn.comDr Reddy’s shares slip nearly 2% on investor concerns amid $50 million foray into anti-vertigo categorySeptember 11, 2025 | msn.comSMC Global’s Shitij Gandhi: Accumulate Dr. Reddy’s for targets of Rs 1,360–1,365September 10, 2025 | msn.comReligare Broking's weekly stock picks: 'Buy' Ashok Leyland, Dr Reddy's & HavellsSeptember 9, 2025 | msn.comDr Reddys Labs UK facility flagged with 7 USFDA observationsSeptember 8, 2025 | msn.comDr Reddy's expects new GST framework to address critical issues impacting pharma sectorAugust 26, 2025 | msn.comJ.P. Morgan Keeps Their Sell Rating on Dr. Reddy’s Laboratories Ltd. (DRREDDY)August 22, 2025 | theglobeandmail.comDr. Reddy’s, Extrovis launch authorized generic of CARAC in the U.S.August 18, 2025 | msn.comDr Reddys Laboratories Ltd spurts 2.42%, rises for fifth straight sessionAugust 13, 2025 | msn.comDr Reddy's Lab receives EIR from USFDA for Telangana API facilityAugust 11, 2025 | msn.comDr Reddys Laboratories Ltd soars 1.07%August 11, 2025 | msn.comDr. Reddy's Laboratories Price Target Cut By Citi Over Intensifying Generic Competition — Full DetailsAugust 4, 2025 | msn.comFive Stocks To Buy: Jio Financial Services, Tata Chemicals, Dr. Reddy's LaboratoriesJuly 30, 2025 | msn.comNomura Sticks to Its Buy Rating for Dr. Reddy’s Laboratories Ltd. (DRREDDY)July 29, 2025 | theglobeandmail.comDr Reddys Laboratories Ltd soars 0.02%, rises for fifth straight sessionJuly 29, 2025 | msn.comSun Pharma, Lupin, Dr Reddy's recall products in US market due to manufacturing issuesJuly 27, 2025 | msn.comDr. Reddy’s Laboratories Ltd. (DRREDDY) Receives a Hold from Goldman SachsJuly 25, 2025 | theglobeandmail.comDr. Reddy’s Laboratories Ltd. (DRREDDY) Gets a Sell from JefferiesJuly 25, 2025 | theglobeandmail.comDr Reddy's Laboratories Q1 Results: Profit Up 1.8%, Misses EstimatesJuly 24, 2025 | msn.comDr Reddy's Q1 FY26 results: PAT up 2% at Rs 1,418 crore, revenue climbs 11%July 24, 2025 | msn.comGoldman Sachs Remains a Hold on Dr. Reddy’s Laboratories Ltd. (DRREDDY)July 18, 2025 | theglobeandmail.comDr. Reddy’s Laboratories Ltd. (DRREDDY) was downgraded to a Hold Rating at MacquarieJuly 12, 2025 | theglobeandmail.comDr. Reddy's Laboratories slides Thursday, underperforms marketJuly 10, 2025 | marketwatch.comDr. Reddy's Laboratories climbs Monday, outperforms competitorsJuly 7, 2025 | marketwatch.comDr. Reddy's Laboratories slides Wednesday, underperforms marketJuly 2, 2025 | marketwatch.comDr. Reddy's Laboratories rises Tuesday, outperforms competitorsJune 25, 2025 | marketwatch.comDr. Reddy's Laboratories slips Friday, underperforms competitorsJune 20, 2025 | marketwatch.comDr. Reddy's Laboratories shares rise 4%: Two factors fueling the rally todayJune 5, 2025 | msn.comDr Reddys Lab gains on global biosimilar deal with AlvotechJune 5, 2025 | msn.comOzempic-Like Drug Not To Be Sold In India, Says Dr Reddy To Delhi High CourtJune 1, 2025 | msn.comDr. Reddy's Laboratories advances Thursday, underperforms marketMay 29, 2025 | marketwatch.comDr Reddys Labs' manufacturing facility gets two form 483 observations from US FDAMay 26, 2025 | msn.comDr. Reddy's Laboratories advances Friday, outperforms competitorsMay 23, 2025 | marketwatch.comDr. Reddy's Laboratories slides Thursday, still outperforms marketMay 22, 2025 | marketwatch.comDr. Reddy's Laboratories slides Monday, underperforms marketMay 19, 2025 | marketwatch.comStock to watch: Dr. Reddy's gets two observations from USFDAMay 19, 2025 | msn.comDr. Reddy’s Labs stock in focus amid FDA inspection report, Q4 resultsMay 19, 2025 | msn.comDr Reddy's receives two USFDA observations for New York API facilityMay 18, 2025 | msn.comDr Reddy's Gets Two Observations From US FDA For New York API PlantMay 17, 2025 | msn.comDr Reddy's NY API plant gets USFDA Form 483 with 2 observationsMay 17, 2025 | msn.comDr. Reddy's Laboratories slides Friday, underperforms competitorsMay 16, 2025 | marketwatch.comDr. Reddy's Laboratories advances Thursday, outperforms competitorsMay 15, 2025 | marketwatch.comDr. Reddy's Laboratories climbs Wednesday, outperforms competitorsMay 14, 2025 | marketwatch.comDr. Reddy’s Shares Eye Breakout As Q4 Beat Lifts Stock Toward ₹1,220 Resistance: SEBI RA Prameela BalakkalaMay 12, 2025 | msn.comDr. Reddy's Laboratories Q4 Results: Profit Rises 22%, Beats EstimatesMay 10, 2025 | msn.comGroup joins Sen. Cassidy to tour Dr. Reddy’s former lab for future economic developmentMay 9, 2025 | msn.comDr. Reddy's Laboratories Q4 Results: Profit Rises 22%, Beats EstimateMay 9, 2025 | msn.comDr. Reddy's Laboratories advances Friday, outperforms marketMay 9, 2025 | marketwatch.com Get Dr Reddy's Laboratories News Delivered to You Automatically Sign up to receive the latest news and ratings for DRREDDY and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. DRREDDY Media Mentions By Week DRREDDY Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. DRREDDY News Sentiment▼0.040.73▲Average News Sentiment DRREDDY News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. DRREDDY Articles This Week▼52▲DRREDDY Articles Average Week Get the Latest News and Ratings for DRREDDY and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Dr Reddy's Laboratories and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:DRREDDY) was last updated on 9/16/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | SponsoredOpenAI’s new $300 billion dealOpenAI just signed a $300 billion cloud deal with Oracle to secure the computing power needed for its next Cha...Porter & Company | SponsoredNvidia CEO Makes First Ever Tesla AnnouncementWhile headlines focus on Tesla’s car sales, tech analyst Jeff Brown says the real story is Tesla’s role in a $...Brownstone Research | SponsoredCollege grad makes $64,000 a monthA Wall Street legend just helped train our own proprietary AI system in the stock market (a project that took ...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Dr Reddy's Laboratories Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Dr Reddy's Laboratories With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
